{"possibly_sensitive": false, "lang": "en", "id": "1268293884133736455", "reply_settings": "everyone", "source": "Twitter for Advertisers.", "author_id": "25950355", "public_metrics": {"retweet_count": 1155, "reply_count": 60, "like_count": 1811, "quote_count": 191}, "text": "In this double-blind, randomized trial, 821 asymptomatic persons with a high- or moderate-risk exposure to #SARSCoV2 were assigned to receive hydroxychloroquine or placebo within 4 days after the exposure. No benefit in preventing illness compatible with #COVID19 was found.", "conversation_id": "1268293884133736455", "created_at": "2020-06-03T21:30:00.000Z", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}], "entities": {"hashtags": [{"start": 107, "end": 116, "tag": "SARSCoV2"}, {"start": 255, "end": 263, "tag": "COVID19"}]}}